Clinical Trial Update: Study of DP303c Injection in Patients With Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for DP303c Injection in advanced ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• DP303c Injection

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN